Cargando…
What can we learn from molecular dynamics simulations for GPCR drug design?
Recent years have seen a tremendous progress in the elucidation of experimental structural information for G-protein coupled receptors (GPCRs). Although for the vast majority of pharmaceutically relevant GPCRs structural information is still accessible only by homology models the steadily increasing...
Autores principales: | Tautermann, Christofer S., Seeliger, Daniel, Kriegl, Jan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334948/ https://www.ncbi.nlm.nih.gov/pubmed/25709761 http://dx.doi.org/10.1016/j.csbj.2014.12.002 |
Ejemplares similares
-
Can molecular dynamics simulations improve the structural accuracy and virtual screening performance of GPCR models?
por: Kapla, Jon, et al.
Publicado: (2021) -
Molecular Design of Luminescent Complexes of Eu(III): What Can We Learn from the Ligands
por: Romanova, Julia, et al.
Publicado: (2023) -
What can we learn from drug marketing efficiency?
por: Kao, David P
Publicado: (2008) -
GPCR Conformations: Implications for Rational Drug Design
por: Parrill, Abby L., et al.
Publicado: (2010) -
Biomedical nanoparticle design: What we can learn from viruses
por: Maslanka Figueroa, Sara, et al.
Publicado: (2021)